NO961333D0 - Nye pyrazolderivater som angiotensin-II-antagonister - Google Patents
Nye pyrazolderivater som angiotensin-II-antagonisterInfo
- Publication number
- NO961333D0 NO961333D0 NO961333A NO961333A NO961333D0 NO 961333 D0 NO961333 D0 NO 961333D0 NO 961333 A NO961333 A NO 961333A NO 961333 A NO961333 A NO 961333A NO 961333 D0 NO961333 D0 NO 961333D0
- Authority
- NO
- Norway
- Prior art keywords
- angiotensin
- antagonists
- pyrazole derivatives
- novel pyrazole
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09401711A ES2105939B1 (es) | 1994-08-02 | 1994-08-02 | Nuevos pirazoles con actividad antagonista de la angiotensina ii. |
PCT/EP1995/003086 WO1996004273A1 (en) | 1994-08-02 | 1995-08-02 | New pyrazole derivatives as angiotensin ii antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961333L NO961333L (no) | 1996-04-01 |
NO961333D0 true NO961333D0 (no) | 1996-04-01 |
Family
ID=8287143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961333A NO961333D0 (no) | 1994-08-02 | 1996-04-01 | Nye pyrazolderivater som angiotensin-II-antagonister |
Country Status (8)
Country | Link |
---|---|
US (1) | US5827863A (no) |
EP (1) | EP0721454A1 (no) |
JP (1) | JPH09504804A (no) |
AU (1) | AU3256395A (no) |
CA (1) | CA2173258A1 (no) |
ES (1) | ES2105939B1 (no) |
NO (1) | NO961333D0 (no) |
WO (1) | WO1996004273A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4432860A1 (de) * | 1994-09-15 | 1996-03-21 | Merck Patent Gmbh | Imidazopyridine |
DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
IL148127A0 (en) * | 1999-08-30 | 2002-09-12 | Aventis Pharma Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
HU222773B1 (hu) * | 2000-04-21 | 2003-10-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás egy ismert tetrazolszármazék előállítására |
DE10105916A1 (de) * | 2001-02-09 | 2002-08-22 | Siemens Ag | Amorphe organische 1,3,2-Dioxaborinluminophore, Verfahren zu deren Herstellung und Verwendung davon |
US7107198B2 (en) * | 2001-11-02 | 2006-09-12 | Sun Microsystems, Inc. | Automatic generation of reduced-size circuit models including inductive interaction |
US20100016396A1 (en) | 2007-01-29 | 2010-01-21 | Hiroshi Imoto | Pyrazole compound |
WO2011005674A1 (en) * | 2009-07-07 | 2011-01-13 | Theravance, Inc. | Dual-acting pyrazole antihypertensive agents |
CN103772282B (zh) * | 2014-02-26 | 2015-09-23 | 上海毕得医药科技有限公司 | 一种3-叔丁基-1h-吡唑-4-甲醛的制备方法 |
JP6639158B2 (ja) | 2014-09-01 | 2020-02-05 | キヤノン株式会社 | 化合物、又はその互変異性体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5189048A (en) * | 1988-01-07 | 1993-02-23 | E. I. Du Pont De Nemours And Company | Substituted 1,2,3 triazole angiotensin II antagonists |
GB9005354D0 (en) * | 1990-03-09 | 1990-05-02 | Glaxo Group Ltd | Chemical compounds |
WO1993005025A1 (en) * | 1991-09-06 | 1993-03-18 | Glaxo Group Limited | C-linked pyrazole derivatives |
AT398202B (de) * | 1991-10-04 | 1994-10-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
-
1994
- 1994-08-02 ES ES09401711A patent/ES2105939B1/es not_active Expired - Lifetime
-
1995
- 1995-08-02 EP EP95929067A patent/EP0721454A1/en not_active Ceased
- 1995-08-02 WO PCT/EP1995/003086 patent/WO1996004273A1/en not_active Application Discontinuation
- 1995-08-02 JP JP8506213A patent/JPH09504804A/ja active Pending
- 1995-08-02 CA CA002173258A patent/CA2173258A1/en not_active Abandoned
- 1995-08-02 AU AU32563/95A patent/AU3256395A/en not_active Abandoned
- 1995-08-02 US US08/624,459 patent/US5827863A/en not_active Expired - Fee Related
-
1996
- 1996-04-01 NO NO961333A patent/NO961333D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996004273A1 (en) | 1996-02-15 |
ES2105939B1 (es) | 1998-07-01 |
ES2105939A1 (es) | 1997-10-16 |
JPH09504804A (ja) | 1997-05-13 |
EP0721454A1 (en) | 1996-07-17 |
US5827863A (en) | 1998-10-27 |
AU3256395A (en) | 1996-03-04 |
NO961333L (no) | 1996-04-01 |
CA2173258A1 (en) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992400D0 (no) | Nye substituerte pyrazolderivater | |
NO983181L (no) | Nye substituerte imidazolforbindelser | |
NO20000226D0 (no) | Nye spiroazabicykliske heterocykliske forbindelser | |
NO20000312D0 (no) | Nye forbindelser | |
NO996572D0 (no) | Nye substituerte imidazolforbindelser | |
NO983356L (no) | Nye 19-nor-pregnenderivater | |
DK0569013T3 (da) | Quinolinforbindelser som angiotensin II antagonister | |
NO20002787D0 (no) | Nye forbindelser | |
DK0885215T3 (da) | Nye benzo-1,3-dioxolyl- og benzofuranyl-substituerede pyrrolidinderivater som endthelinantagonister | |
NO974605D0 (no) | Nye heterosykliske forbindelser | |
FI961628A0 (fi) | Indolijohdannaisia NMDA-antagonisteina | |
DK0922034T3 (da) | Tetrahydroquinolinderivater som EAA-antagonister | |
NO974043L (no) | Indolderivater som EAA-antagonister | |
DK0854867T3 (da) | Tetrahydroquinoliner som NMDA-antagonister | |
NO961333D0 (no) | Nye pyrazolderivater som angiotensin-II-antagonister | |
NO960268D0 (no) | Nye dialkoksypyridinylbenzimidazolderivater | |
FI951798A0 (fi) | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina | |
NO950684L (no) | Nye imidazopyridinderivater som angiotensin II-antagonister | |
EE03615B1 (et) | Pürasool-4-üülhetaroüülderivaadid herbitsiididena | |
NO992066D0 (no) | Piperazinoderivater som neurokininantagonister | |
NO995653L (no) | Cis-substituerte aminocykloalkyl-pyrrolidin-derivater | |
FI943359A0 (fi) | Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina | |
NO981216D0 (no) | Nye heterosykliske forbindelser | |
DK0946548T3 (da) | Nye heterocykliske substituerede pyrrolidinamidderivater | |
NO20002575D0 (no) | Substituerte oksimer som neurokininantagonister |